Friday, July 10, 2026

pharma · infections · Not applicable (submitted trial is a BE study in healthy participants)

Zaklady FarmaFarmaceutyczne Polpharma

Zaklady FarmaFarmaceutyczne Polpharma clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

EU HQ
EMA registrant Type
Company details
Status
Public
HQ
EU
Programs
6
Drugs
15
Patents
0
Intelligence · Clinical Programs

Zaklady FarmaFarmaceutyczne Polpharma projects

6 ClinicalTrials.gov programs sponsored by Zaklady FarmaFarmaceutyczne Polpharma.

Zaklady FarmaFarmaceutyczne Polpharma has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 01-AMO-CLA-BIO-25

    Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.

    infections

    phase 1 other active

    1 trial
  2. 01-DAP-BIO-24

    Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.

    intended for treatment of for the treatment of (2): • insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise. • symptomatic chronic heart failure. • chronic kidney disease.

    phase 1 other active

    1 trial
  3. A single-dose for infection

    Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.

    infection

    phase 1 other active

    1 trial
  4. A single-dose for infections

    Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.

    infections

    phase 1 other active

    1 trial
  5. Bioequivalence Study of Empagliflozin

    Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.

    Not applicable (submitted trial is a BE study in healthy participants)

    phase 1 other active

    1 trial
  6. Pharmacokinetic study of colistimethate sodium

    Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.

    serious infections caused by selected aerobic gram-negative pathogens in patients with limited treatment options

    phase 1 other active

    1 trial

Frequently asked questions

How many clinical projects does Zaklady FarmaFarmaceutyczne Polpharma have?

6 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.